STAT3 contributes to cisplatin resistance, modulating EMT markers, and the mTOR signaling in lung adenocarcinoma.
Morelli AP, Tortelli TC Jr, Mancini MCS, Pavan ICB, Silva LGS, Severino MB, Granato DC, Pestana NF, Ponte LGS, Peruca GF, Pauletti BA, Dos Santos DFG Jr, de Moura LP, Bezerra RMN, Leme AFP, Chammas R, Simabuco FM.
Morelli AP, et al. Among authors: ponte lgs.
Neoplasia. 2021 Sep 17;23(10):1048-1058. doi: 10.1016/j.neo.2021.08.003. Online ahead of print.
Neoplasia. 2021.
PMID: 34543857
Free PMC article.